Table 2 Antibiotic susceptibility of MDR, XDR and ESBL E coli isolates
| Â | No. of resistant isolates (%) | |||
|---|---|---|---|---|
Antibiotics | Total isolates (%) | MDR (n = 480)% | XDR (n = 37)% | ESBL (n = 288)% |
Ampicillin | 645(87) | 480(100) | 37(100) | 288(100) |
Amoxicillin-clavulanate | 355(48) | 407(84.7) | 37(100) | 288(100) |
Piperacillin-tazobactam | 244(33) | 91(19) | 37(100) | 78(27) |
Cephalexin | 645(87) | 392(81.6) | 37(100) | 265(92) |
Cefixime | 525(71) | 312(65) | 37(100) | 288(100) |
Ceftazidime | 333(45) | 306(64) | 37(100) | 288(100) |
Ceftriaxone | 333(45) | 306(64) | 37(100) | 288(100) |
Aztreonam | 318(43) | 294(61) | 37(100) | 288(100) |
Imipenem | 37(5) | 37(8) | 37(100) | 28(10) |
Gentamycin | 244(33) | 130(27) | 37(100) | 118(41) |
Amikacin | 103(14) | 64(13) | 37(100) | 52(18) |
Ciprofloxacin | 576(78) | 387(80.6) | 37(100) | 225(78) |
Levofloxacin | 495(67) | 245(51) | 37(100) | 155(54) |
Cotrimoxazole | 310(42) | 158(33) | 37(100) | 141(49) |
Tigecycline | 0(0) | 0(0) | 0(0) | 0(0) |
Colistin | 0(0) | 0(0) | 0(0) | 0(0) |